Lyra Therapeutics Inc. (LYRA): Price and Financial Metrics

Lyra Therapeutics Inc. (LYRA): $0.30

0.01 (-4.80%)

POWR Rating

Component Grades








LYRA Price/Volume Stats

Current price $0.30 52-week high $6.79
Prev. close $0.31 52-week low $0.29
Day low $0.29 Volume 1,748,900
Day high $0.31 Avg. volume 1,982,469
50-day MA $2.35 Dividend yield N/A
200-day MA $3.91 Market Cap 18.00M

LYRA Stock Price Chart Interactive Chart >

Lyra Therapeutics Inc. (LYRA) Company Bio

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer and is headquartered in Watertown, MA.

LYRA Latest News Stream

Event/Time News Detail
Loading, please wait...

LYRA Latest Social Stream

Loading social stream, please wait...

View Full LYRA Social Stream

Latest LYRA News From Around the Web

Below are the latest news stories about LYRA THERAPEUTICS INC that investors may wish to consider to help them evaluate LYRA as an investment opportunity.

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow

Novo Nordisk (NVO), Journey Medical Corporation (DERM), Lyra Therapeutics (LYRA) and Fusion Pharmaceuticals (FUSN) have returned 40% or higher year to date and have room for more growth in 2024.

Yahoo | December 20, 2023

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical

Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical are part of the Zacks Industry Outlook article.

Yahoo | December 12, 2023

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

Innovation is expected to continue driving growth in the Medical-Drugs industry. DERM, LYRA, AUPH, ALPN and HARP may prove to be good additions to one's portfolio.

Yahoo | December 11, 2023

Lyra Therapeutics Insider Ups Holding By 11% During Year

Insiders were net buyers of Lyra Therapeutics, Inc.'s ( NASDAQ:LYRA ) stock during the past year. That is, insiders...

Yahoo | November 15, 2023

Executive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More Shares

Whilst it may not be a huge deal, we thought it was good to see that the Lyra Therapeutics, Inc. ( NASDAQ:LYRA...

Yahoo | November 15, 2023

Read More 'LYRA' Stories Here

LYRA Price Returns

1-mo -18.39%
3-mo -94.94%
6-mo -94.25%
1-year -90.10%
3-year -96.75%
5-year N/A
YTD -94.27%
2023 66.88%
2022 -27.98%
2021 -61.75%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!